Psychiatry and Neurology, Neurology · Moscow, ID
NPI
1922449453
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
619 S Washington St
Moscow, ID, 83843
Phone (208) 813-7519
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
582 services
Medicare patients, 2024
222
Average age 72
Drug cost, 2024
$1.2M
1,323 prescriptions
Company payments, 2025
$157
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarita Said-Said was code 99214 (office e&m - established), 197 times for 119 patients. In total Sarita Said-Said billed 582 services in 21 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 197 | 119 | $87.55 | $17K |
| 95886 Electrical Nerve Conductivity | Office | 112 | 67 | $65.90 | $7,381 |
| 95885 Electrical Nerve Conductivity | Office | 73 | 46 | $40.21 | $2,935 |
| 95913 Electrical Nerve Conductivity | Office | 60 | 60 | $203.46 | $12K |
| 99205 Office E&M - New | Office | 39 | 39 | $157.95 | $6,160 |
| 99215 Office E&M - Established | Office | 32 | 28 | $127.39 | $4,076 |
| 95912 Electrical Nerve Conductivity | Office | 19 | 18 | $180.77 | $3,435 |
| 95911 Electrical Nerve Conductivity | Office | 13 | 13 | $145.83 | $1,896 |
By year: 2022 $36K for 421 services; 2023 $43K for 452 services; 2024 $57K for 582 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarita Said-Said prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 177 prescriptions and refills. In total Sarita Said-Said wrote 1,323 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 177 | 270 | 33 | $4,672 |
| Gabapentin Generic | 124 | 157 | 24 | $1,400 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 110 | 140 | 20 | $2,067 |
| Baclofen Generic | 79 | 81 | Under 11 | $1,164 |
| Pregabalin Generic | 66 | 66 | Under 11 | $1,505 |
| Methocarbamol Generic | 58 | 58 | 22 | $299 |
| Aimovig Autoinjector Erenumab-Aooe | 42 | 42 | Under 11 | $30K |
| Propranolol Hcl Generic | 40 | 54 | Under 11 | $387 |
| Entacapone Generic | 39 | 41 | Under 11 | $1,550 |
| Acetazolamide Generic | 37 | 47 | Under 11 | $5,809 |
| Levetiracetam Generic | 36 | 44 | Under 11 | $710 |
| Nurtec Odt Rimegepant Sulfate | 32 | 32 | Under 11 | $44K |
| Nortriptyline Hcl Generic | 31 | 33 | Under 11 | $295 |
| Qulipta Atogepant | 29 | 29 | Under 11 | $29K |
| Topiramate Generic | 28 | 35 | Under 11 | $109 |
Brand drugs: 218 claims; generic drugs: 1,105 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarita Said-Said $157 ($157 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $52.89.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.